A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.

Slides:



Advertisements
Similar presentations
Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
Advertisements

TEMPLATE DESIGN © MAXIMAL ISOMETRIC HANDGRIP STRENGTH IS ASSOCIATED WITH MEASURES OF PHYSICAL HEALTH IN OLDER ADULTS Tyler.
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Continuous Glucose Monitoring
Ambulatory Blood Pressure Profiles in Adolescents with Type 1 Diabetes Andrew J. Ellis 1,2, B.A.; David M. Maahs 2, M.D. Ph.D.; Franziska K. Bishop 2,
Association of 1,5-Anhydroglucitol with Diabetes and Microvascular
Diabetes Update: Living Life after Lente
Oral Glucose Tolerance Test By: Dr. Beenish Zaki Date: 09/05/2012 Senior Instructor Department of Biochemistry.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Management Tools and CGM Kathryn Moe, RN CDE Medtronic Diabetes.
A STUDY OF RURAL CHILDHOOD OBESITY Dr. Marilyn Duran PhD, RN Department of Nursing Tarleton State University.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
Diabetes Technology Update
GDM DIAGNOSIS AND MANAGEMENT
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
Chronic Diabetes Case F Gestational Diabetes Mellitus (GDM) Clinical Pathology B Hoa Nguyen Tuan Anh Tran Thi Thuy Duong Trang.
Closed-Loop Insulin Delivery in Children
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
ACANTHOSIS NIGRICANS IN SCHOOL AGE CHILDREN IN FORT WORTH TEXAS Ximena Urrutia-Rojas, DrPH John A. Menchaca, MD Naveed Ahmad, MD Manuel Bayona, MD, PhD.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free- Living, Randomized Clinical Trial Featured Article: Roman Hovorka,
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Type I Diabetes Mellitus
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
P UMPMASTER AND G LUCOMMANDER THE FAR SIDE OF THE DIABETES WORLD Presented by Paul Davidson MD at the MiniMed Symposium Atlanta, GA December 13, 2003.
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
Special Situations In The Management Of In-Patient Hyperglycemia
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Date of download: 6/24/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Daniel A. Baur, Fernanda S. Vargas, Jordan A. Garvey, Christopher W. Bach, and Michael J Ormsbee, FACSM Institute of Sports Sciences and Medicine, Department.
Table 1 Descriptive Variables __________________________________________________________________________________________ Variables M (SD) Min. Max. n*
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Key publication slides
Clinical Experience of an Iontophoresis Based Glucose Measuring System
بايو كمستري (م 3) / د . احمد الطويل
Key publication slides
GLUCOSE TOLERANCE TEST (GTT)
Clinical Performance.
Campbell FM, et al. Pediatr Diabetes. 2018;19(7):1294–1301
Presentation transcript:

A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce Buckingham 1, Roy Beck 2, Katrina Ruedy 2, Craig Kollman 2, Eva Tsalikian 4, Timothy Wysocki 5, Stuart Weinzimer 3, Peter Chase 6 and the Diabetes Research in Children Network (DirecNet) Study Group 1 Stanford, CA; 2 Tampa, FL; 3 New Haven, CT; 4 Iowa City, IA; 5 Jacksonville, FL; 6 Denver, CO.

Background The Diabetes Research in Children Network (DirecNet) is a NIH-funded collaborative study group. The major objective of DirecNet is to critically evaluate the clinical usefulness of current and future glucose sensor devices in youth with T1DM.

Goals The purpose of this study was to determine the accuracy of the GlucoWatch® G2™ Biographer (GW2B) in children with Type 1 diabetes mellitus (T1DM).

GlucoWatch ® G2 ™ Biographer (GW2B) Measures interstitial glucose extracted by reverse iontophoresis Requires a single calibration value following the 2-hour warm-up period Glucose readings every 10 minutes for 13 hours Values range from 40 to 400 mg/dL

Subject Selection Age 1 to 18 years T1DM for at least 1 year BMI between 5 th and 95 th percentile for age and gender Weight ≥ 12.0 kg if < 7 yrs and ≥ 16.0 kg if ≥ 7 yrs Normal hematocrit No skin or other significant disorders

Study Procedures Admitted to Clinical Research Center Approximately 24 hours Two GW2Bs placed at staggered times Sensor pads were replaced as needed Venous blood sampling Hourly during day (7:00AM to 9:00PM) Twice hourly during night (9:30PM to 6:30AM) Central lab for reference glucoses

Study Procedures Meal induced hyperglycemia high carbohydrate drink 1.75 gm CHO/kg, maximum of 75 grams Samples q 5 minutes for 60 minutes Insulin induced hypoglycemia Subjects older than 7 years only units/kg regular insulin IV bolus After 30 minutes, a second dose if needed Glycemia goal of ≤ 55 mg/dL Samples q 5 minutes for up to 90 minutes

GlucoWatch Function Sensor calibration 1 st attempt 94% 2 nd attempt 2% Failed 4% Sensor lifespan* ≥14.5 hours (Full)81% 10.0 to 14.5 hours 3% 6.0 to 10.0 hours 6% <6.0 hours10% Of 14,232 possible GW2B measurements 17% were skipped * Excludes sensors stopped early for logistical reasons.

Evaluation of Accuracy The appropriate set of accuracy measures to evaluate near continuous glucose monitoring remains to be developed. We used the traditional methods that are utilized to assess the accuracy of blood glucose meters. These methods do not adequately capture the time dimension of glucose sensor data with respect to glucose trend (slope) information or glucose pattern detection across the day.

Measures of Accuracy Pearson’s correlation Difference sensor – reference Relative difference % (sensor – reference)/reference x 100% Absolute difference |sensor – reference| Relative absolute difference (RAD) % |(sensor – reference)/reference| x 100%

Measures of Accuracy ISO criteria (proposed) Reference glucose ≤75 mg/dL Sensor value within ±15 mg/dL Reference glucose value >75 mg/dL Sensor value within ±20% Error grid analysis Clarke Consensus

Subject Characteristics 89 Subjects Gender44 (49%) F 45 (51%) M Age (years) mean ± SD 9.9 ± 4.1 Duration of diabetes (years) mean ± SD 4.6 ± 3.2 Insulin delivery 39 (44%) pump 50 (56%) injections HbA1c mean ± SD 7.8% ± 1.2% BMI percentile mean ± SD 67% ± 23%

A Subject

GW2B Accuracy Summary 3,672 paired values Median difference, 3 mg/dL, Not significantly different than zero Median absolute relative difference 16% Correlation 0.86 Consensus Error Grid 97%, A+B zones

GW2B Accuracy Mean (95% CI) Median (25 th to 75 th %-ile) Difference mg/dL 2.2 (-2.0, 6.1) 3 (-19, 26) Absolute Difference mg/dL 30.9 (28.7, 33.2) 23 (11, 42) Relative Difference 6% (4%, 9%) 2% (-12%, 20%) Relative Absolute Difference 22% (20%, 23%) 16% (7%, 29%)

Factors NOT Impacting Accuracy Age Gender BMI (body mass index) Time (6:30AM -10:30PM vs 11PM – 6AM) Location of GWB placement Upper vs lower arm Inner vs outer arm

Factors Impacting Accuracy Sensor Age Sensor age (hrs) Number of paired values RAD (median) ISO criteria met (%) 0 to <6 hr1,31615%63% 6 to <10 hr1,14215%64% ≥10 hr1,21419%54% p value

Factors Impacting Accuracy Glucose Concentration Glucose (mg/dL) Number of paired values RAD (median) ISO criteria met (%) ≤ %32% %55% %66% %66% > %67% p value<0.001

Clarke Error Grid

Consensus Error Grid

Detection of Hypoglycemia Episode defined as at least two GW2B values ≤ 60 mg/dL without any values > 70 mg/dL. Distinct episodes had to be separated by at least 30 minutes. Episode was considered confirmed if there was at least one reference glucose value ≤ 70 mg/dL. Only 10 of 18 hypoglycemic episodes detected by the GW2B overnight were confirmed.

Alarm=60 Alarm=100 Alarm=80 Alarm=120 Receiver Operator Curve (ROC) for Hypoglycemia ( ≤60 mg/dL) Alarm Setting SensitivityFalse Alarm Rate 6023%51% 8059%67% 10084%80% 12092%85%

Side Effects No serious skin reactions No other problems Moderate Irritation example Mild Irritation example

Summary In summary, our results are very similar to those reported in studies conducted by Cygnus, Inc. We found the GW2B to be more accurate during periods of hyperglycemia than hypoglycemia. The accuracy of this generation of the sensor does not approach the accuracy of current home glucose meters. However, the sensor glucose values are generally within 20% of the serum glucose. This level of accuracy may be sufficient for detecting trends and modifying diabetes management.

Acknowledgements This study would not have been possible without the support of CRC Nurses at the study sites. This research has been supported by the following NIH/NICHD Grants: HD ; HD041915; HD041890; HD ; HD ; and HD Clinical Centers also received funding through the following GCRC Grant Numbers M01 RR00069; RR00059; M01 RR and 5M01RR and Nemours Biomedical Research. University of Minnesota Central Laboratory Michael Steffes, Jean Bucksa, Maren Nowicki